Volatility, uncertainty, complexity, and ambiguity (VUCA) have plagued medtech’s supply chain since the pandemic. Drug shortages last year hit their highest levels in a decade, with 99% of hospital and health system pharmacists experiencing medicinal dearths, according to an American Society of Health System Pharmacists (ASHP) survey.
The medical device market is expected to grow by almost $178 billion from 2023 to 2027 according to Technavio. Moreover, a Fortune Business Insights Analysis estimates the market to reach $799 billion by 2030. With such significant growth, manufacturing and supply chains must scale and mitigate risk to ensure supplies to customers and patients.
COVID-19 may no longer be a significant public health threat, but the global supply chain remains chock full of risk. The threats are seemingly everywhere these days: The Israel-Hamas war, which is sabotaging trade routes in the Red Sea; extreme drought, which is curtailing shipping in the Panama Canal, and China’s military aggression, which is threatening lawful commerce in the South China Sea.
Although the supply chain challenges have abated since the COVID-19 pandemic, disruptions continue to persist and risks have increased. VUCA (volatility, uncertainty, complexity, ambiguity) has increased substantially in the world, negatively impacting the safety, security, and reliability of the supply chain.
Lisa Anderson participated on a panel discussion to discuss nearshoring in the Medtech industry with Steven A. Colantuoni, Director of Corporate Marketing, The Central American Group, Yarisol Lopez, Deputy Executive Director, National Free Zones Council of the Dominican Republic, and Carlos Wong, Managing Director, Coyol Free Zone (Costa Rica).
MPO Magazine: The Big Shift: Nearshoring Trends in Medtech Manufacturing "Medical device companies are on the move," said Lisa Anderson, president of LMA Consulting Group, a Claremont, Calif.-based consulting firm that specializes in manufacturing strategy and end-to-end supply chain transformation."For example, Costa Rica continues to gain significant nearshoring opportunities".
Supply chain disruptions will likely persist well into 2024 and beyond as hospitals, healthcare providers, and medical device companies continually pivot to address the market's immediate needs, creating further disruption and misalignment comments Lisa Anderson, founder and president of LMA Consulting Group Inc., a consulting firm specializing in manufacturing strategy and end-to-end supply chain transformation.
